Susceptible locus for obese type 2 diabetes mellitus in the 5'-flanking region of the tumor necrosis factor-α gene

Tissue Antigens

Volumn 55, Issue 5, 2000, Pages 449-452

  Kamizono, S ^a   Yamada, Kentaro ^a   Seki, N ^a   Higuchi, T ^a   Kimura, A ^b   Nonaka, K ^a   Itoh, K ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Diabetes mellitus; Obesity; Polymorphism; Promoter region; TNF gene

Indexed keywords

GLUCOSE; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; AGED; CONTROLLED STUDY; DIABETIC OBESITY; DNA FLANKING REGION; ENHANCER REGION; FEMALE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GLUCOSE TOLERANCE; HOMOZYGOTE; HUMAN; HUMAN CELL; IMMUNOGENETICS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEIC ACID BASE SUBSTITUTION; PRIORITY JOURNAL; PROMOTER REGION; SHORT SURVEY;

5' UNTRANSLATED REGIONS; ADOLESCENT; ADULT; AGED; ALLELES; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 2; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HOMOZYGOTE; HUMANS; MALE; MIDDLE AGED; OBESITY; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034026635     PISSN: 00012815     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0039.2000.550508.x     Document Type: Short Survey

References (20)

1. 1. Kern PA, Saghizadeh M, Ong JM, Bosch RJ, Deem R, Simsolo RB. The expression of tumor necrosis factor in human adipose tissue: regulation by obesity, weight loss, and relationship to lipoprotein lipase. J Clin Invest 1995: 95: 2111-9.
2. 2. Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-α: direct role in obesity-linked insulin resistance. Science 1993: 259: 87-91.
3. 3. Hotamisligil GS, Budavari A, Murray D, Spiegelman BM. Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. Central role of tumor necrosis factor-alpha. J Clin Invest 1994: 94: 1543-9.
4. 4. Stephens JM, Lee J, Pilch PF. Tumor necrosis factor-alpha-induced insulin resistance in 3T3-L1 adipocytes is accompanied by a loss of insulin receptor substrate-1 and GLUT4 expression without a loss of insulin receptor-mediated signal transduction. J Biol Chem 1997: 272: 971-6.
5. 5. Uysal KT, Wiesbrock SM, Marino MW, Hotamisligil GS. Protection from obesity-induced insulin resistance in mice lacking TNF-α function. Nature 1997: 389: 610-4.
6. 6. Hofmann C, Lorenz K, Braithwaite SS et al. Altered gene expression for tumor necrosis factor-alpha and its receptors during drug and dietary modulation of insulin resistance. Endocrinology 1994: 134: 264-70.
7. 7. Wilson AG, di Giovine FS, Blakemore AI, Duff GW. Single base polymorphism in the human tumour necrosis factor alpha (TNF alpha) gene detectable by NcoI restriction of PCR product. Hum Mol Gen 1992: 1: 353.
8. 8. D'Alfonso S, Richiardi PM. A polymorphic variation in a putative regulation box of the TNFA promoter region. Immunogenetics 1994: 39: 150-4.
9. 9. McGuire W, Hill AVS, Allsopp CEM, Greenwood BM. Kwiatkowski D. Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria. Nature 1994: 371: 508-10.
10. 10. Albuquerque RV, Hayden CM, Palmer LJ et al. Association of polymorphisms within the tumour necrosis factor (TNF) genes and childhood asthma, Clin Exp Allergy 1998: 28: 578-84.
11. 11. Sullivan KE, Wooten C, Schmeckpeper BJ, Goldman D, Petri MA. A promoter polymorphism of tumor necrosis factor alpha associated with systemic lupus erythematosus in African-Americans. Arthritis Rheum 1997: 40: 2207-11.
12. 12. Vinasco J, Beraun Y, Nieto A et al. Polymorphism at the TNF loci in rheumatoid arthritis. Tissue Antigens 1997: 49: 74-8.
13. 13. Hohler T, Kruger A, Gerken G, Schneider PM, Meyer zum Buschenfelde KH, Rittner C. Tumor necrosis factor alpha promoter polymorphism at position -238 is associated with chronic active hepatitis C infection. Med Virol 1998: 54: 173-7.
14. 14. Grove J, Daly AK, Bassendine MF, Day CP. Association of a tumor necrosis factor promoter polymorphism with susceptibility to alcoholic steatohepatitis. Hepatology 1997: 26: 143-6.
15. 15. Hamann A, Mantzoros C, Vidal-Puig A, Flier JS. Genetic variability in the TNF-α promoter is not associated with type II diabetes mellitus (NIDDM). Biochem Biophys Res Commun 1995: 211: 833-9.
16. 16. Fernández-Real JM, Gutierrez C, Ricart W et al. The TNF-α gene NcoI polymorphism influences the relationship among insulin resistance, percent body fat, and increased serum leptin levels. Diabetes 1997: 46: 1468-72.
17. 17. Day CP, Grove J, Daly AK, Stewart MW, Avery PJ, Walker M. Tumour necrosis factor-alpha gene promoter polymorphism and decreased insulin resistance. Diabetologia 1998: 41: 430-4.
18. 18. Higuchi T, Seki N, Kamizono S et al. Polymorphism of the 5′-flanking region of human tumor necrosis factor (TNF)-α gene in Japanese. Tissue Antigens 1998: 51: 605-12.
19. 19. WHO Expert Committee. Second report on diabetes mellitus. WHO Technical Report Series, No.646. Geneva: World Health Organization, 1980.
20. 20. Uglialoro AM, Turbay D, Pesavento PA et al. Identification of three new single nucleotide polymorphisms in the human tumor necrosis factor-alpha gene promoter. Tissue Antigens 1998: 52: 359-67.